G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization.


Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
15 12 2019
Historique:
received: 18 02 2019
revised: 31 05 2019
accepted: 03 06 2019
pubmed: 8 6 2019
medline: 15 7 2020
entrez: 8 6 2019
Statut: ppublish

Résumé

Amphetamine (AMPH) acts as a substrate of the dopamine transporter (DAT) and causes a dramatic increase in extracellular dopamine (DA). Upon entering DA neurons, AMPH promotes DA efflux via DAT through a mechanism implicating depletion of DA from vesicular stores, activation of kinase pathways and transporter phosphorylation. Despite the role of intracellular signaling for AMPH action, it remains elusive how the response to AMPH is affected in vivo by metabotropic regulation via G protein coupled receptor signaling pathways. Here, we show by employment of Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) that the acute hyperlocomotor response to AMPH is bidirectionally regulated by metabotropic input to VTA DA neurons with a markedly enhanced response upon activation of a Gs-coupled pathway and a markedly decreased locomotor response upon activation of a Gi-coupled pathway. The unique mechanism of action for AMPH was underlined by the absence of an effect of Gs activation on the locomotor response to the DAT inhibitor cocaine. Regardless of the profound effect on the acute AMPH response, repeated Gs activation or Gi activation did not affect development of AMPH sensitization. Furthermore, activation of a Gs-pathway or activation of a Gi-pathway in DA neurons did not have any effect on the AMPH-induced locomotor response in the AMPH sensitized mice. This suggests induction of alterations in DA neuronal functions that overrule the stimulatory or inhibitory effect of metabotropic input seen in drug-naïve mice. The data thereby underline the remarkable strength of maladaptive changes that occur upon intake of strong psychostimulants. This article is part of the issue entitled 'Special Issue on Neurotransmitter Transporters'.

Identifiants

pubmed: 31173760
pii: S0028-3908(19)30209-6
doi: 10.1016/j.neuropharm.2019.06.002
pii:
doi:

Substances chimiques

Central Nervous System Stimulants 0
Designer Drugs 0
Dopamine Plasma Membrane Transport Proteins 0
Receptors, G-Protein-Coupled 0
Slc6a3 protein, mouse 0
Amphetamine CK833KGX7E
Cocaine I5Y540LHVR

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107663

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Annika H Runegaard (AH)

Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark.

Ditte Dencker (D)

Laboratory of Neuropsychiatry, Psychiatric Center Copenhagen and Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark.

Gitta Wörtwein (G)

Laboratory of Neuropsychiatry, Psychiatric Center Copenhagen and Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark.

Ulrik Gether (U)

Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark. Electronic address: gether@sund.ku.dk.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH